Evexia Lifecare Limited has submitted a regulatory disclosure to BSE Limited pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
The Board of Directors meeting is scheduled for Friday, August 07, 2026. The primary agenda is to consider and approve the Audited Financial Results (both Standalone and Consolidated) for the quarter ended June 30, 2026.
Additionally, the company has confirmed that the trading window closure period, implemented under the company's Code of Conduct for Prohibition of Insider Trading, will conclude 48 hours after the financial results for the June 2026 quarter are made public following their official declaration.
The disclosure serves as formal intimation to the stock exchange for information and record-keeping purposes.
Designation: Jayeshbhai R. Thakkar, Chairman & Managing Director
DIN: 01631093